31Indexed trials
mesh condition
Amyotrophic Lateral Sclerosis
Intelligence
Amyotrophic Lateral Sclerosis intelligence: 31 indexed trials, 6 recruiting studies, 28 sponsors across 27 countries.
6Recruiting
28Sponsors
27Countries
Leading sponsors
Beth Israel Deaconess Medical Center20 recruiting
Merit E. Cudkowicz, MD20 recruiting
Amylyx Pharmaceuticals Inc.20 recruiting
Avanir Pharmaceuticals10 recruiting
Biohaven Pharmaceuticals, Inc.10 recruiting
Dartmouth-Hitchcock Medical Center10 recruiting
King's College London10 recruiting
Johns Hopkins University10 recruiting
Jagiellonian University10 recruiting
MD Stem Cells11 recruiting
Mallinckrodt10 recruiting
Biogen10 recruiting
Geographic activity
United States21trials
Germany4trials
France3trials
Poland3trials
United Kingdom3trials
Italy3trials
Portugal2trials
Belgium2trials
Puerto Rico2trials
Canada2trials
Denmark2trials
Argentina2trials
Leading interventions
Matching Placebo2trials
AMX00352trials
Baricitinib1trials
BHV-02231trials
Incobotulinum Toxin A1trials
DNL3431trials
Flutemetamol F18 Injection1trials
Elecsys (Roche) Abeta42, Ttau and Ptau1trials
HealthPAL1trials
Imaging Techniques (MRI 3T & 7T, Functional, Structural, and Metabolic Imaging)1trials
Acthar1trials
120% of individual calory requirement1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.